When can children with conditions be in no-benefit, higher-hazard pediatric studies?

American Journal of Bioethics

Volumn 7, Issue 3, 2007, Pages 15-17

  Kopelman, Loretta M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; CHILD; ETHICS; HUMAN; HUMAN EXPERIMENT; JUVENILE; LEGAL ASPECT; NOTE; OBESITY; POVERTY; RESEARCH SUBJECT; RISK ASSESSMENT; SOCIAL JUSTICE;

ADVISORY COMMITTEES; CHILD; HUMANS; MINORS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; OBESITY; POVERTY; RESEARCH SUBJECTS; RISK ASSESSMENT; SOCIAL JUSTICE;

EID: 33947244965     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160601171614     Document Type: Note

References (15)

1. Council for International Organizations of Medical Science (CIOMS). 2002. International ethical guidelines for biomedical research involving human subjects. Geneva, CH: CIOMS.
2. Department of Health and Human Services. 1991 [2002]. Protection of human subjects. 45 C.F.R. §46. Available at http:// www.hhs.gov/humansubjects/ guidance/45cfr46.htm (accessed January 17, 2007).
3. Fisher, C. B., S. Z. Kornetsky, and E. D. Prentice. 2007. Determining risk in pediatric research with no prospect of direct benefit: Time for a national consensus on the interpretation for pediatric regulations. American Journal of Bioethics 7(3): 5-10.
4. Institute of Medicine (IOM). 2004, The ethical conduct of clinical research involving children. Washington, DC: National Academy of Sciences.
5. Janofsky, J., and B. Starfield. 1981. Assessment of risk and research on children. Journal of Pediatrics 98(5): 842-846.
6. Kopelman, L. M. 2000. Children as Research Subjects: A Dilemma. The Journal of Medicine and Philosophy 25(6): 745-764.
7. Kopelman, L. M. 2004a. Minimal risk as an international ethical standard in research. Journal of Medicine and Philosophy 29(3): 351- 378.
8. Kopelman, L. M. 2004b. What conditions justify risky nontherapeutic or "no benefit" pediatric studies: A sliding scale analysis. The Journal of Law, Medicine and Ethics. 32(4): 749-758.
9. Kopelman, L. M., and T. Murphy. 2004. Ethical concerns about risky research. Pediatrics 113(6): 1783-1789.
10. Merriam-Webster Online. Available at http://www.m-w/ dictionary/ condition.
11. National Bioethics Advisory Commission (NBAC). 2001. Ethical and policy issues in research involving human participants, volume I: Report and recommendations. Bethesda, MD: NBAC.
12. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1977. Report and recommendations: Research involving children.Washington, DC: Department of Health, Education and Welfare.
13. National Human Research Protections Advisory Committee (NHRPAC). 2006. Children's Workgroup draft report. Available at http://www.hhs.gov / ohrp / nhrpac / documents / nhrpac16.pdf (accessed December 21, 2006).
14. Secretary's Advisory Committee for Human Research Protections (SACHRP). 2006. Meeting minutes. Available at http:// www.hhs.gov/ohrp/sachrp/ mtgings/mtg04-05/mtg04-05.htm (accessed December 21, 2006).
15. Shah, A., B. Whittle, B. Wilfond, G. Gensler, and D. Wendler. 2004. How do Institutional Review Boards apply the federal risk and benefit standards for pediatric research?Journal of the American Medical Association 291: 4.